Form D · Other Technology
REPLICEL LIFE SCIENCES INC.
Vancouver Bc, A1 · CIK 0001205059
Offering snapshot reported Dec 16, 2024 · SEC filing
- Reported sold
- $224K Offering amount: $224K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 26, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 16, 2024 | Initial | $223,665 | No comparison | 2 | SEC filing |
| Mar 16, 2023 | Initial | $740,778 | No comparison | 5 | SEC filing |
| Feb 8, 2023 | Initial | $9,196 | No comparison | 1 | SEC filing |
| Jan 26, 2023 | Initial | $86,942 | No comparison | 2 | SEC filing |
| Jan 6, 2023 | Initial | $558,837 | No comparison | 2 | SEC filing |
| May 10, 2022 | Initial | $592,728 | No comparison | 2 | SEC filing |
| Dec 20, 2021 | Initial | $777,659 | No comparison | 1 | SEC filing |
| Jun 14, 2021 | Amendment | $161,520 | $49,946vs Jun 3, 2021 | 3 | SEC filing |
| Jun 3, 2021 | Initial | $111,574 | No comparison | 2 | SEC filing |
| May 27, 2021 | Initial | $9,012 | No comparison | Not reported | SEC filing |
| Feb 26, 2021 | Initial | $385,848 | No comparison | 1 | SEC filing |
| Aug 20, 2020 | Initial | $118,181 | No comparison | 2 | SEC filing |
| Jul 24, 2020 | Initial | $447,064 | No comparison | 2 | SEC filing |
| Nov 4, 2019 | Initial | $135,078 | No comparison | 1 | SEC filing |
| Sep 13, 2019 | Initial | $76,030 | No comparison | 1 | SEC filing |
| Jan 22, 2019 | Initial | $20,883 | No comparison | 1 | SEC filing |
| Oct 26, 2017 | Initial | $267,158 | No comparison | 2 | SEC filing |
| Jan 9, 2017 | Initial | $8,536 | No comparison | 1 | SEC filing |
| Nov 8, 2016 | Initial | $112,274 | No comparison | 3 | SEC filing |
| Jul 6, 2015 | Initial | $143,033 | No comparison | 3 | SEC filing |
| Apr 19, 2013 | Initial | $70,210 | No comparison | 2 | SEC filing |
| May 24, 2012 | Initial | $245 | No comparison | 1 | SEC filing |
| Apr 25, 2012 | Initial | $594,050 | No comparison | 6 | SEC filing |
| Apr 4, 2012 | Initial | $272,998 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-532175
CDN$314,977.78. Based on the Bank of Canada exchange rate of 0.7101 as at November 26, 2024. Consists of the issuance of common shares.
Source: Form D, filed Dec 16, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ben Austring | Executive |
| Gary Boddington | Director |
| Lee Buckler | Director |
| John Richard George Challis | Director |
| David Hall | Director, Executive |
| Rolf Hoffman | Director, Executive |
| Rolf Hoffmann | Executive |
| Larissa Huang | Director |
| Peter Jensen | Director, Executive |
| Tom Kordyback | Executive |
| David Kwok | Executive |
| Peter Lewis | Director |
| Peter Lowry | Director |
| Simon Ma | Executive |
| Jamie Mackay | Director |
| Geoff Mackay | Director |
| Kevin Mcelwee | Executive |
| Kevin Mc Elwee | Executive |
| Hugh Rogers | Promoter |
| Andrew Schutte | Director, Executive |
| Gavin Ye | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
Suite 900 570 Granville Street
Vancouver Bc, A1, V6C 3P1
Vancouver Bc, A1, V6C 3P1